Expand XFOR Menu
XFOR MENU

XFOR Latest Press Releases

-- November 5, 2025 --

X4 Pharmaceuticals to Participate in Guggenheim's Second Annual Healthcare Innovation Conference Globe Newswire 4:01 PM
X4 Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update Globe Newswire 7:00 AM

-- October 27, 2025 --

X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million Globe Newswire 7:05 PM

-- October 24, 2025 --

X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering Globe Newswire 12:37 AM

-- October 23, 2025 --

X4 Pharmaceuticals Announces Proposed Underwritten Public Offering Globe Newswire 4:01 PM

-- September 29, 2025 --

Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide Globe Newswire 7:30 AM

-- September 17, 2025 --

X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation Globe Newswire 7:00 AM

-- September 8, 2025 --

Sitryx appoints Adam Mostafa as Chief Financial Officer Globe Newswire 7:00 AM

-- August 15, 2025 --

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- August 13, 2025 --

X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement Globe Newswire 7:00 AM

-- August 12, 2025 --

X4 Pharmaceuticals Announces $60 Million Equity Financing with Concurrent Changes in Management and Board Leadership Globe Newswire 7:00 AM
X4 Pharmaceuticals Announces $60 Million Equity Financing with Concurrent Changes in Management and Board Leadership Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes